‘Fast-fail’ AI blood test could steer patients with pancreatic cancer away from ineffective therapies

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood could help clinicians more quickly identify and determine if pancreatic cancer therapies are working.